{"id":97418,"date":"2026-05-26T09:35:08","date_gmt":"2026-05-26T04:05:08","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=97418"},"modified":"2026-05-26T09:35:10","modified_gmt":"2026-05-26T04:05:10","slug":"dr-lal-path-labs-ltd-analyst-review-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/dr-lal-path-labs-ltd-analyst-review-2026\/","title":{"rendered":"Dr. Lal Path Labs Ltd. Analyst Review May 2026"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p>This <strong><a href=\"https:\/\/univest.in\/user\/stocks\/lalpathlab\/dr-lal-pathlabs-ltd-share-price-today\">Dr. Lal Path Labs Ltd.<\/a> analyst review<\/strong> for May 2026 covers all critical data investors need for LALPATHLAB at Rs 1614.90. Dr. Lal PathLabs is a leading national diagnostics chain. This <strong>Dr. Lal Path Labs Ltd. analyst review<\/strong> analyses technical levels, business fundamentals, valuation, and key risks for LALPATHLAB through FY27.<\/p>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/dr-lal-path-labs-ltd-analyst-review-2026\/#Dr_Lal_Path_Labs_Ltd_Analyst_Review_Company_Snapshot_May_2026\" title=\"Dr. Lal Path Labs Ltd. Analyst Review: Company Snapshot May 2026\">Dr. Lal Path Labs Ltd. Analyst Review: Company Snapshot May 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/dr-lal-path-labs-ltd-analyst-review-2026\/#Analyst_Insight_Dr_Lal_Path_Labs_Ltd_Analyst_Review_for_FY27\" title=\"Analyst Insight: Dr. Lal Path Labs Ltd. Analyst Review for FY27\">Analyst Insight: Dr. Lal Path Labs Ltd. Analyst Review for FY27<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/dr-lal-path-labs-ltd-analyst-review-2026\/#Technical_Analysis_in_This_Dr_Lal_Path_Labs_Ltd_Analyst_Review\" title=\"Technical Analysis in This Dr. Lal Path Labs Ltd. Analyst Review\">Technical Analysis in This Dr. Lal Path Labs Ltd. Analyst Review<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/dr-lal-path-labs-ltd-analyst-review-2026\/#Support_and_Resistance_in_This_Dr_Lal_Path_Labs_Ltd_Analyst_Review\" title=\"Support and Resistance in This Dr. Lal Path Labs Ltd. Analyst Review\">Support and Resistance in This Dr. Lal Path Labs Ltd. Analyst Review<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/dr-lal-path-labs-ltd-analyst-review-2026\/#Business_Segments_in_This_Dr_Lal_Path_Labs_Ltd_Analyst_Review\" title=\"Business Segments in This Dr. Lal Path Labs Ltd. Analyst Review\">Business Segments in This Dr. Lal Path Labs Ltd. Analyst Review<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/dr-lal-path-labs-ltd-analyst-review-2026\/#Pathology_and_Clinical_Labs_National_Network\" title=\"Pathology and Clinical Labs (National Network)\">Pathology and Clinical Labs (National Network)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/dr-lal-path-labs-ltd-analyst-review-2026\/#Radiology_and_Imaging_Services\" title=\"Radiology and Imaging Services\">Radiology and Imaging Services<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/dr-lal-path-labs-ltd-analyst-review-2026\/#Home_Collection_and_Digital_Diagnostics\" title=\"Home Collection and Digital Diagnostics\">Home Collection and Digital Diagnostics<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/dr-lal-path-labs-ltd-analyst-review-2026\/#Valuation_Dr_Lal_Path_Labs_Ltd_Analyst_Review_Bull_Bear_Base_Case\" title=\"Valuation: Dr. Lal Path Labs Ltd. Analyst Review Bull Bear Base Case\">Valuation: Dr. Lal Path Labs Ltd. Analyst Review Bull Bear Base Case<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/dr-lal-path-labs-ltd-analyst-review-2026\/#FY27_Outlook_in_This_Dr_Lal_Path_Labs_Ltd_Analyst_Review\" title=\"FY27 Outlook in This Dr. Lal Path Labs Ltd. Analyst Review\">FY27 Outlook in This Dr. Lal Path Labs Ltd. Analyst Review<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/dr-lal-path-labs-ltd-analyst-review-2026\/#Key_Risks_in_This_Dr_Lal_Path_Labs_Ltd_Analyst_Review\" title=\"Key Risks in This Dr. Lal Path Labs Ltd. Analyst Review\">Key Risks in This Dr. Lal Path Labs Ltd. Analyst Review<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/dr-lal-path-labs-ltd-analyst-review-2026\/#Conclusion_Dr_Lal_Path_Labs_Ltd_Analyst_Review_Verdict_May_2026\" title=\"Conclusion: Dr. Lal Path Labs Ltd. Analyst Review Verdict May 2026\">Conclusion: Dr. Lal Path Labs Ltd. Analyst Review Verdict May 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/dr-lal-path-labs-ltd-analyst-review-2026\/#FAQs_Dr_Lal_Path_Labs_Ltd_Analyst_Review_2026\" title=\"FAQs: Dr. Lal Path Labs Ltd. Analyst Review 2026\">FAQs: Dr. Lal Path Labs Ltd. Analyst Review 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/dr-lal-path-labs-ltd-analyst-review-2026\/#What_is_the_analyst_target_for_Dr_Lal_Path_Labs_Ltd_in_2026\" title=\"What is the analyst target for Dr. Lal Path Labs Ltd. in 2026?\">What is the analyst target for Dr. Lal Path Labs Ltd. in 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/dr-lal-path-labs-ltd-analyst-review-2026\/#Is_Dr_Lal_Path_Labs_Ltd_a_good_buy_at_Rs_161490\" title=\"Is Dr. Lal Path Labs Ltd. a good buy at Rs 1614.90?\">Is Dr. Lal Path Labs Ltd. a good buy at Rs 1614.90?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/dr-lal-path-labs-ltd-analyst-review-2026\/#What_is_the_52-week_high_and_low_of_Dr_Lal_Path_Labs_Ltd\" title=\"What is the 52-week high and low of Dr. Lal Path Labs Ltd.?\">What is the 52-week high and low of Dr. Lal Path Labs Ltd.?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/dr-lal-path-labs-ltd-analyst-review-2026\/#What_are_the_key_risks_for_Dr_Lal_Path_Labs_Ltd\" title=\"What are the key risks for Dr. Lal Path Labs Ltd.?\">What are the key risks for Dr. Lal Path Labs Ltd.?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/dr-lal-path-labs-ltd-analyst-review-2026\/#Where_can_I_track_live_data_for_Dr_Lal_Path_Labs_Ltd\" title=\"Where can I track live data for Dr. Lal Path Labs Ltd.?\">Where can I track live data for Dr. Lal Path Labs Ltd.?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Dr_Lal_Path_Labs_Ltd_Analyst_Review_Company_Snapshot_May_2026\"><\/span><strong>Dr. Lal Path Labs Ltd. Analyst Review: Company Snapshot May 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Dr. Lal PathLabs operates 250 plus clinical labs and 4,000 plus collection centres across India providing pathology, radiology, and wellness testing services. The table below summarises key metrics for this <strong>Dr. Lal Path Labs Ltd. analyst review<\/strong>.<\/p>\n<table>\n<tbody>\n<tr>\n<th>Parameter<\/th>\n<th>Value<\/th>\n<\/tr>\n<tr>\n<td>NSE Ticker<\/td>\n<td>LALPATHLAB<\/td>\n<\/tr>\n<tr>\n<td>Sector<\/td>\n<td>Healthcare &#8211; Diagnostics<\/td>\n<\/tr>\n<tr>\n<td>CMP (May 2026)<\/td>\n<td>Rs 1614.90<\/td>\n<\/tr>\n<tr>\n<td>52 Week High<\/td>\n<td>Rs 1937.80<\/td>\n<\/tr>\n<tr>\n<td>52 Week Low<\/td>\n<td>Rs 1292.00<\/td>\n<\/tr>\n<tr>\n<td>Market Cap<\/td>\n<td>Rs 18500 Crore<\/td>\n<\/tr>\n<tr>\n<td>Trailing P\/E<\/td>\n<td>45x<\/td>\n<\/tr>\n<tr>\n<td>Analyst Consensus Target<\/td>\n<td>Rs 2018.62<\/td>\n<\/tr>\n<tr>\n<td>Bull Case Target<\/td>\n<td>Rs 2503.10<\/td>\n<\/tr>\n<tr>\n<td>Bear Case Target<\/td>\n<td>Rs 1372.66<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Analyst_Insight_Dr_Lal_Path_Labs_Ltd_Analyst_Review_for_FY27\"><\/span><strong>Analyst Insight: Dr. Lal Path Labs Ltd. Analyst Review for FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Senior Research Analyst <strong>Ankit Jaiswal<\/strong> flags Dr. Lal Path Labs Ltd. as a stock to watch in May 2026. At Rs 1614.90, Ankit Jaiswal identifies key support in the Rs 1317.84 to Rs 1534.15 band and resistance near Rs 1711.79. He suggests watching Dr. Lal Path Labs Ltd. for a potential move toward Rs 2018.62. Ankit Jaiswal&#8217;s view in this <strong>Dr. Lal Path Labs Ltd. analyst review<\/strong> does not constitute a trade recommendation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Technical_Analysis_in_This_Dr_Lal_Path_Labs_Ltd_Analyst_Review\"><\/span><strong>Technical Analysis in This Dr. Lal Path Labs Ltd. Analyst Review<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>This <strong>Dr. Lal Path Labs Ltd. analyst review<\/strong> places LALPATHLAB at Rs 1614.90 within its 52-week band of Rs 1292.00 to Rs 1937.80. The 14-day RSI, MACD signal, and volume profile are key technical inputs when evaluating LALPATHLAB.<\/p>\n<p>The <strong>Dr. Lal Path Labs Ltd. analyst review<\/strong> identifies support in the Rs 1317.84 to Rs 1534.15 range and resistance in the Rs 1711.79 to Rs 1816.76 zone. A sustained close above Rs 1711.79 could signal momentum toward the analyst consensus target of Rs 2018.62.<\/p>\n<p><a href=\"https:\/\/univest.in\/screeners\"><strong>Screen the best stocks on the Univest Screener.<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Support_and_Resistance_in_This_Dr_Lal_Path_Labs_Ltd_Analyst_Review\"><\/span><strong>Support and Resistance in This Dr. Lal Path Labs Ltd. Analyst Review<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Support Zone:<\/strong> Rs 1317.84 to Rs 1534.15 &#8211; this <strong>Dr. Lal Path Labs Ltd. analyst review<\/strong> identifies this as a potential accumulation signal for LALPATHLAB.<\/li>\n<li><strong>Resistance Zone:<\/strong> Rs 1711.79 to Rs 1816.76 &#8211; the <strong>Dr. Lal Path Labs Ltd. analyst review<\/strong> flags a close above Rs 1711.79 as a positive signal for LALPATHLAB.<\/li>\n<li><strong>Consensus Target:<\/strong> Rs 2018.62 is the base-case target in this <strong>Dr. Lal Path Labs Ltd. analyst review<\/strong>.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Business_Segments_in_This_Dr_Lal_Path_Labs_Ltd_Analyst_Review\"><\/span><strong>Business Segments in This Dr. Lal Path Labs Ltd. Analyst Review<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Pathology_and_Clinical_Labs_National_Network\"><\/span><strong>Pathology and Clinical Labs (National Network)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>This primary segment drives revenue and margin for Dr. Lal Path Labs Ltd., supporting the earnings trajectory toward Rs 2018.62 in this <strong>Dr. Lal Path Labs Ltd. analyst review<\/strong>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Radiology_and_Imaging_Services\"><\/span><strong>Radiology and Imaging Services<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>This segment adds meaningful scale to Dr. Lal Path Labs Ltd.&#8217;s model and is a key EPS contributor through FY27 as identified in this <strong>Dr. Lal Path Labs Ltd. analyst review<\/strong>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Home_Collection_and_Digital_Diagnostics\"><\/span><strong>Home Collection and Digital Diagnostics<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>This growth frontier is a potential re-rating catalyst for LALPATHLAB and a key element of this <strong>Dr. Lal Path Labs Ltd. analyst review<\/strong>.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Valuation_Dr_Lal_Path_Labs_Ltd_Analyst_Review_Bull_Bear_Base_Case\"><\/span><strong>Valuation: Dr. Lal Path Labs Ltd. Analyst Review Bull Bear Base Case<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>At Rs 1614.90 and P\/E of 45x, this <strong>Dr. Lal Path Labs Ltd. analyst review<\/strong> sets three scenarios: bull case Rs 2503.10, base case Rs 2018.62, and bear case Rs 1372.66.<\/p>\n<table>\n<tbody>\n<tr>\n<th>Scenario<\/th>\n<th>Target Price<\/th>\n<th>Key Condition<\/th>\n<\/tr>\n<tr>\n<td>Bull Case<\/td>\n<td>Rs 2503.10<\/td>\n<td>Strong FY27 delivery and Healthcare &#8211; Diagnostics re-rating<\/td>\n<\/tr>\n<tr>\n<td>Base Case<\/td>\n<td>Rs 2018.62<\/td>\n<td>Moderate growth per analyst consensus in this Dr. Lal Path Labs Ltd. analyst review<\/td>\n<\/tr>\n<tr>\n<td>Bear Case<\/td>\n<td>Rs 1372.66<\/td>\n<td>Earnings miss or macro headwinds for LALPATHLAB<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"FY27_Outlook_in_This_Dr_Lal_Path_Labs_Ltd_Analyst_Review\"><\/span><strong>FY27 Outlook in This Dr. Lal Path Labs Ltd. Analyst Review<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>This <strong>Dr. Lal Path Labs Ltd. analyst review<\/strong> for FY27 is constructive provided LALPATHLAB delivers on earnings expectations. Q1 FY27 results will be the first checkpoint. Investors should monitor Healthcare &#8211; Diagnostics indicators, RBI policy, and FII flow trends.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_in_This_Dr_Lal_Path_Labs_Ltd_Analyst_Review\"><\/span><strong>Key Risks in This Dr. Lal Path Labs Ltd. Analyst Review<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>This <strong>Dr. Lal Path Labs Ltd. analyst review<\/strong> identifies four key risks for LALPATHLAB: macro slowdown, input cost pressure, FII selling, and Q1 FY27 earnings disappointment.<\/p>\n<p>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or the <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to get daily stock recommendations and expert research.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion_Dr_Lal_Path_Labs_Ltd_Analyst_Review_Verdict_May_2026\"><\/span><strong>Conclusion: Dr. Lal Path Labs Ltd. Analyst Review Verdict May 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>This <strong>Dr. Lal Path Labs Ltd. analyst review<\/strong> concludes that LALPATHLAB at Rs 1614.90 presents a defined risk-reward with consensus target Rs 2018.62. The 52-week range of Rs 1292.00 to Rs 1937.80 provides further context. Use this <strong>Dr. Lal Path Labs Ltd. analyst review<\/strong> as a research reference and consult a SEBI-registered advisor before investing in LALPATHLAB.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"FAQs_Dr_Lal_Path_Labs_Ltd_Analyst_Review_2026\"><\/span><strong>FAQs: Dr. Lal Path Labs Ltd. Analyst Review 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_analyst_target_for_Dr_Lal_Path_Labs_Ltd_in_2026\"><\/span><strong>What is the analyst target for Dr. Lal Path Labs Ltd. in 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The <strong>Dr. Lal Path Labs Ltd. analyst review<\/strong> consensus target is Rs 2018.62, bull case Rs 2503.10, bear case Rs 1372.66.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Dr_Lal_Path_Labs_Ltd_a_good_buy_at_Rs_161490\"><\/span><strong>Is Dr. Lal Path Labs Ltd. a good buy at Rs 1614.90?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>At Rs 1614.90 with PE 45x and target Rs 2018.62, this <strong>Dr. Lal Path Labs Ltd. analyst review<\/strong> is constructive for 12-month investors. Consult a SEBI-registered advisor before acting on this <strong>Dr. Lal Path Labs Ltd. analyst review<\/strong>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_52-week_high_and_low_of_Dr_Lal_Path_Labs_Ltd\"><\/span><strong>What is the 52-week high and low of Dr. Lal Path Labs Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>52-week high is Rs 1937.80 and 52-week low is Rs 1292.00. This <strong>Dr. Lal Path Labs Ltd. analyst review<\/strong> contextualises LALPATHLAB at Rs 1614.90 within this range.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_risks_for_Dr_Lal_Path_Labs_Ltd\"><\/span><strong>What are the key risks for Dr. Lal Path Labs Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Key risks in this <strong>Dr. Lal Path Labs Ltd. analyst review<\/strong>: macro slowdown, input cost pressure, FII selling, and competitive pressure in the Healthcare &#8211; Diagnostics sector.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Where_can_I_track_live_data_for_Dr_Lal_Path_Labs_Ltd\"><\/span><strong>Where can I track live data for Dr. Lal Path Labs Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><span style=\"box-sizing: border-box; margin: 0px; padding: 0px;\">Track Dr Lal Path Labs Ltd.&#8217;s live price on the Univest Screener to complement this\u00a0<strong>Dr Lal Path Labs Ltd. analyst review<\/strong> with real-time data.<\/span><\/p>\n<p><em>Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. Please consult a SEBI-registered financial advisor before making any investment decisions.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dr. Lal Path Labs Ltd. analyst review 2026: CMP Rs 1614.90, MCap Rs 18500 Cr, PE 45x. Healthcare &#8211; Diagnostics outlook. May 2026.<\/p>\n","protected":false},"author":26,"featured_media":97444,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-97418","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1779768326:26"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["71"],"rank_math_focus_keyword":["Dr. Lal Path Labs Ltd. Analyst Review"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"rank_math_title":["Dr. Lal Path Labs Ltd. Analyst Review 2026"],"rank_math_description":["Dr. Lal Path Labs Ltd. analyst review 2026: CMP Rs 1614.90, MCap Rs 18500 Cr, PE 45x. Healthcare - Diagnostics outlook. May 2026."],"_wp_old_date":["2026-05-25"],"_thumbnail_id":["97444"],"_edit_last":["26"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["13403"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/05\/Dr.-Lal-Path-Labs-Ltd.-Analyst-Review.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/97418","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/26"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=97418"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/97418\/revisions"}],"predecessor-version":[{"id":97447,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/97418\/revisions\/97447"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/97444"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=97418"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=97418"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=97418"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}